Mark Hartmann
@mphartmann.bsky.social
Scientist at DKFZ and NCT Heidelberg
#epigenetics #stemcells #leukemia #colorectalcancer #multiomics #precisiononcology
#oncofetal #reprogramming
#plasticity
www.translational-cancer-epigenomics.de
#epigenetics #stemcells #leukemia #colorectalcancer #multiomics #precisiononcology
#oncofetal #reprogramming
#plasticity
www.translational-cancer-epigenomics.de
October 7, 2025 at 8:26 PM
Pioneers of Epigenetics honored: Davor Solter & Azim Surani receive the 2026 Paul Ehrlich & Ludwig Darmstaedter Prize. Their discovery of genomic imprinting revealed why mammals need both parents—opening the field of epigenetics.
#Epigenetics #GenomicImprinting #PaulEhrlichPrize #CanSky #Science
#Epigenetics #GenomicImprinting #PaulEhrlichPrize #CanSky #Science
September 26, 2025 at 4:17 PM
Pioneers of Epigenetics honored: Davor Solter & Azim Surani receive the 2026 Paul Ehrlich & Ludwig Darmstaedter Prize. Their discovery of genomic imprinting revealed why mammals need both parents—opening the field of epigenetics.
#Epigenetics #GenomicImprinting #PaulEhrlichPrize #CanSky #Science
#Epigenetics #GenomicImprinting #PaulEhrlichPrize #CanSky #Science
Summer Selection of the International #PhD Program at the German Cancer Research Center (@dkfz.bsky.social)
Apply here: t1p.de/amwgq
#CancerResearch
#DataScience
#Bioinformatics
#SolidCancer
#Leukemia
#ChildhoodCancer
#RareCancer
#CanSky
#OncoSky
#HemeSky
Apply here: t1p.de/amwgq
#CancerResearch
#DataScience
#Bioinformatics
#SolidCancer
#Leukemia
#ChildhoodCancer
#RareCancer
#CanSky
#OncoSky
#HemeSky
March 19, 2025 at 2:12 PM
Summer Selection of the International #PhD Program at the German Cancer Research Center (@dkfz.bsky.social)
Apply here: t1p.de/amwgq
#CancerResearch
#DataScience
#Bioinformatics
#SolidCancer
#Leukemia
#ChildhoodCancer
#RareCancer
#CanSky
#OncoSky
#HemeSky
Apply here: t1p.de/amwgq
#CancerResearch
#DataScience
#Bioinformatics
#SolidCancer
#Leukemia
#ChildhoodCancer
#RareCancer
#CanSky
#OncoSky
#HemeSky
Actually, not so rare at all!
#RareDiseaseDay
Affecting a substantial part of human kind!
Support research on rare diseases!
Picture from rarediseaseday.org
#RareDiseaseDay
Affecting a substantial part of human kind!
Support research on rare diseases!
Picture from rarediseaseday.org
February 28, 2025 at 7:27 PM
Actually, not so rare at all!
#RareDiseaseDay
Affecting a substantial part of human kind!
Support research on rare diseases!
Picture from rarediseaseday.org
#RareDiseaseDay
Affecting a substantial part of human kind!
Support research on rare diseases!
Picture from rarediseaseday.org
What a fantastic meeting! Thrilled to welcome Frank Westermann, Katrin Ottersbach, and Jan-Henning Klusmann to the @dkfz.bsky.social to dive into the developmental origins of #ChildhoodCancers.
November 15, 2024 at 3:34 PM
What a fantastic meeting! Thrilled to welcome Frank Westermann, Katrin Ottersbach, and Jan-Henning Klusmann to the @dkfz.bsky.social to dive into the developmental origins of #ChildhoodCancers.
Excited to announce the upcoming 80th Heidelberg Grand Round on
"Developmental Signatures and Molecular Plasticity in Cancer"!
Heidelberg, on Nov 14, 2024, from 4:00-6:00 PM.
Explore #Cancer as a developmental disease!
@dkfz.bsky.social
NCT Heidelberg
Universitätsklinikum Heidelberg
"Developmental Signatures and Molecular Plasticity in Cancer"!
Heidelberg, on Nov 14, 2024, from 4:00-6:00 PM.
Explore #Cancer as a developmental disease!
@dkfz.bsky.social
NCT Heidelberg
Universitätsklinikum Heidelberg
November 8, 2024 at 2:24 PM
Excited to announce the upcoming 80th Heidelberg Grand Round on
"Developmental Signatures and Molecular Plasticity in Cancer"!
Heidelberg, on Nov 14, 2024, from 4:00-6:00 PM.
Explore #Cancer as a developmental disease!
@dkfz.bsky.social
NCT Heidelberg
Universitätsklinikum Heidelberg
"Developmental Signatures and Molecular Plasticity in Cancer"!
Heidelberg, on Nov 14, 2024, from 4:00-6:00 PM.
Explore #Cancer as a developmental disease!
@dkfz.bsky.social
NCT Heidelberg
Universitätsklinikum Heidelberg
Exciting insights by Andi Roy into the role of the fetal HSPC marker LIN28B on human lymphopoiesis and infant ALL at the EMBO Workshop Intercepting Childhood Blood Cancer in Düsseldorf.
#ChildhoodCancer
#bloodsky
#ChildhoodCancer
#bloodsky
May 5, 2024 at 9:04 AM
Exciting insights by Andi Roy into the role of the fetal HSPC marker LIN28B on human lymphopoiesis and infant ALL at the EMBO Workshop Intercepting Childhood Blood Cancer in Düsseldorf.
#ChildhoodCancer
#bloodsky
#ChildhoodCancer
#bloodsky
Great talk from @laurenmharmon.bsky.social from @timtriche.bsky.social lab about germline variant burden in pediatric AML.
#bloodsky
#bloodsky
May 3, 2024 at 3:50 PM
Great talk from @laurenmharmon.bsky.social from @timtriche.bsky.social lab about germline variant burden in pediatric AML.
#bloodsky
#bloodsky
Today is #internationalchildhoodcancerday! 🎗️
Picture from KITZ - Hopp Children‘s Cancer Center Heidelberg
Picture from KITZ - Hopp Children‘s Cancer Center Heidelberg
February 15, 2024 at 6:55 AM
Today is #internationalchildhoodcancerday! 🎗️
Picture from KITZ - Hopp Children‘s Cancer Center Heidelberg
Picture from KITZ - Hopp Children‘s Cancer Center Heidelberg
Do you think fetal transcription signatures are the consequence of a maturation block of a prenatal cell-of-origin in #childhoodcancer ?
This might not always be true!
Evidence for #oncofetal #reprogramming can be found in our new preprint @dblipka.bsky.social
www.biorxiv.org/content/10.1...
This might not always be true!
Evidence for #oncofetal #reprogramming can be found in our new preprint @dblipka.bsky.social
www.biorxiv.org/content/10.1...
February 9, 2024 at 3:02 PM
Do you think fetal transcription signatures are the consequence of a maturation block of a prenatal cell-of-origin in #childhoodcancer ?
This might not always be true!
Evidence for #oncofetal #reprogramming can be found in our new preprint @dblipka.bsky.social
www.biorxiv.org/content/10.1...
This might not always be true!
Evidence for #oncofetal #reprogramming can be found in our new preprint @dblipka.bsky.social
www.biorxiv.org/content/10.1...